ASCRX Performance — Small Company Fund, R Class
Data updated: 2026-09-14
ASCRX returned +25.64% year to date and +41.78% over one year to Jun 2026. Annualised returns are +17.75% over 3 years and +6.88% over 5 years. The fund beat its US Small Growth category average: $100 invested three years ago grew to $163, against $156 for the category, and to $142 over one year, against $132. Volatility over the past three years was 18.47% a year. In the 12 months to Jun 2026 the fund lost a net $5.8M, and assets reached $195.15M.
ASCRX Growth of $100
What $100 invested in Small Company Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Growth category average over the same months.
| Period | ASCRX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $142 | $132 |
| 3 years (Jul 2023 – Jun 2026) | $163 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $139 | $127 |
| Since data start (Jul 2019 – Jun 2026) | $204 | $203 |
ASCRX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +25.64% |
| 1 year | +41.78% |
| 3 years (annualised) | +17.75% |
| 5 years (annualised) | +6.88% |
ASCRX Annual Returns
Calendar-year total returns of Small Company Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +25.64% |
| 2025 | +12.40% |
| 2024 | +3.96% |
| 2023 | +20.64% |
| 2022 | −21.79% |
| 2021 | +20.39% |
| 2020 | +15.87% |
| 2019 (Jul–Dec) | +5.42% |
ASCRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.4% | +1.1% | −4.3% | +12.6% | +4.1% | +6.1% | — | — | — | — | — | — |
| 2025 | +2.9% | −4.7% | −6.3% | −1.5% | +5.7% | +4.2% | +2.2% | +6.6% | +0.8% | −0.1% | +1.8% | +1.1% |
| 2024 | −2.2% | +4.1% | +3.3% | −7.1% | +4.0% | −2.4% | +10.1% | −2.5% | +0.1% | −2.4% | +9.1% | −8.4% |
| 2023 | +9.0% | −1.3% | −5.2% | −1.6% | −0.7% | +8.9% | +5.7% | −2.6% | −4.0% | −6.2% | +8.2% | +10.8% |
| 2022 | −8.2% | +1.0% | −0.4% | −8.9% | +0.1% | −10.2% | +9.5% | −3.7% | −8.7% | +11.7% | +2.8% | −6.5% |
| 2021 | +3.9% | +7.4% | +1.3% | +4.1% | +0.8% | +0.8% | −2.9% | +1.9% | −3.0% | +5.0% | −3.0% | +3.1% |
| 2020 | −3.1% | −9.6% | −22.1% | +14.3% | +7.0% | +3.9% | +4.1% | +3.0% | −2.4% | +2.0% | +15.2% | +8.7% |
| 2019 | — | — | — | — | — | — | +1.0% | −5.5% | +2.3% | +3.1% | +3.2% | +1.5% |
ASCRX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 18.47%
- 3-year Sharpe ratio: 0.72 (vs 4.5% risk-free rate)
- Best month: +12.61% (Apr 2026)
- Worst month: −8.44% (Dec 2024)
ASCRX Fund Flows
Monthly money in and out of Small Company Fund, from SEC Form N-PORT.
- 12-month net flow: −$5.8M
- 12-month gross sales (incl. reinvestments): $19.2M
- Sales ÷ redemptions: 0.77×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $3.0M | $5.3M | −$2.3M |
| May 2026 | $2.5M | $1.3M | $1.2M |
| Apr 2026 | $1.5M | $1.9M | −$396K |
| Mar 2026 | $582K | $1.1M | −$554K |
| Feb 2026 | $1.2M | $1.9M | −$685K |
| Jan 2026 | $2.6M | $2.0M | $686K |
| Dec 2025 | $4.8M | $3.1M | $1.7M |
| Nov 2025 | $489K | $1.6M | −$1.1M |
| Oct 2025 | $641K | $2.0M | −$1.4M |
| Sep 2025 | $797K | $1.9M | −$1.1M |
| Aug 2025 | $349K | $1.3M | −$997K |
| Jul 2025 | $694K | $1.6M | −$880K |
ASCRX Assets Under Management
Net assets of Small Company Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $195.15M |
| 2026-03-31 | $157.88M |
| 2025-12-31 | $156.70M |
| 2025-09-30 | $156.61M |
| 2025-06-30 | $145.39M |
| 2025-03-31 | $136.93M |
| 2024-12-31 | $154.65M |
| 2024-09-30 | $162.90M |
| 2024-06-30 | $155.32M |
| 2024-03-31 | $168.00M |
| 2023-12-31 | $165.58M |
| 2023-09-30 | $150.15M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.